Literature DB >> 26381712

Role of Water in the Puzzling Mechanism of the Final Aromatization Step Promoted by the Human Aromatase Enzyme. Insights from QM/MM MD Simulations.

Jacopo Sgrignani1, Marcella Iannuzzi2, Alessandra Magistrato1.   

Abstract

The enzyme human aromatase (HA) catalyzes the conversion of androgens to estrogens via two hydroxylation reactions and a final unique aromatization step. Despite the great interest of HA as a drug target against breast cancer detailed structural and spectroscopic information on this enzyme became available only in the past few years. As such, the enigmatic mechanism of the final aromatization step is still a matter of debate. Here, we investigated the final step of the HA enzymatic cycle via hybrid quantum-classical (QM/MM) metadynamics and blue-moon ensemble simulations. Our results show that the rate-determining step of the aromatization process is the nucleophilic attack of the distal oxygen of a peroxo-ferric species on the formyl carbon of the enol-19-oxo-androstenedione, which occurs with a free energy barrier (ΔF(#)) of ∼ 16.7 ± 1.9 kcal/mol, in good agreement with experimental data. This reaction is followed by a water mediated 1β-hydrogen abstraction (ΔF(#) = 7.9 ± 0.8 kcal/mol) and by the formation of a hydroxo-ferric moiety. This latter may be finally protonated by a hydrogen delivery channel involving Asp309 and Thr310, both residues pointed out as crucial for HA activity. In the absence of the catalytic water in the active site the substrate does not assume a position suitable to undergo the nucleophilic attack. Our data not only reveal a novel possible mechanism for the aromatization process consistent with some of the spectroscopic and kinetic data available in the literature, complementing current knowledge on the mechanism of this enzyme, but also point out a remarkable influence of the level of theory used on the calculated free energy barriers. The structural information obtained in this study may be used for the rational structure-based drug design of HA inhibitors to be employed in breast cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26381712     DOI: 10.1021/acs.jcim.5b00249

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors.

Authors:  Jessica Caciolla; Angelo Spinello; Silvia Martini; Alessandra Bisi; Nadia Zaffaroni; Silvia Gobbi; Alessandra Magistrato
Journal:  ACS Med Chem Lett       Date:  2020-03-23       Impact factor: 4.345

2.  Dynamics Insights Into the Gain of Flexibility by Helix-12 in ESR1 as a Mechanism of Resistance to Drugs in Breast Cancer Cell Lines.

Authors:  Abbas Khan; Muhammad Junaid; Cheng-Dong Li; Shoaib Saleem; Fahad Humayun; Shazia Shamas; Syed Shujait Ali; Zainib Babar; Dong-Qing Wei
Journal:  Front Mol Biosci       Date:  2020-01-24

3.  A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers.

Authors:  Matic Pavlin; Angelo Spinello; Marzia Pennati; Nadia Zaffaroni; Silvia Gobbi; Alessandra Bisi; Giorgio Colombo; Alessandra Magistrato
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.